MedTrace Logo

Study to Evaluate the Effect of a Probiotic in COVID-19

NCT04390477 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2022-04-29

No results posted yet for this study

Summary

A prospective case-control pilot study to evaluate the possible effect of a probiotic mixture in the improvement of symptoms, the reduction in the number of days of hospitalization and the increase in the percentage of patients with negative PCR after infection with the coronavirus SARS-CoV-2.

Conditions

Interventions

DIETARY_SUPPLEMENT

Probiotic

Oral daily capsule containing probiotic strains with maltodextrin as excipient, administrated for 30 days.

Sponsors & Collaborators

  • Bioithas SL

    lead INDUSTRY

Principal Investigators

  • Vicente Navarro · Hospital universitario del Vinalopo, Elche, Spain

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-04
Primary Completion
2021-03-21
Completion
2021-04-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04390477 on ClinicalTrials.gov